Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Clasificación en acciones #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Precio por acción
$0.78611575
Capitalización bursátil
$60.45M
Cambio (1 día)
0.00%
Cambio (1 año)
-12.06%
País
NO
Comercio Lytix Biopharma AS (LYTIX)

Categoría

Historial del precio de la acción de Lytix Biopharma AS (LYTIX)
Precio más alto de cierre: $0.83 el 2026-08-01

Precio más bajo de cierre: $1.84 el 2021-06-01
Historial del precio de la acción de Lytix Biopharma AS desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$546.40 37.47%
US
$1.05K 57.85%
NL
$118.70 -18.24%
AU
$140.43 435.58%
US
$770.19 9.84%
CH